“alzheimers” Archives

in
Entry Author Date Location
Technology to Assess Neurons Gives New Life to San Diego’s Afraxis 08/19/13 San Diego
East Coast Life Sciences Roundup: Epizyme, Rodin, Ophthotech, & More 08/16/13 Boston
Why Deborah Dunsire’s Unusual Bet on Alzheimer’s Makes Sense 07/31/13 Boston
East Coast Life Sciences Roundup: Alkermes, Ensemble, Sinai, & More 07/19/13 Boston
San Diego Life Sciences Roundup: Regulus, Ocera, Lithera, and More 07/18/13 San Diego
MI Biotech Roundup: Rockwell, Metabolic Solutions Publish New Data 07/18/13 Detroit Ann Arbor
Dunsire Returns to Action to Tackle CNS Disorders With EnVivo 07/11/13 Boston
Supply Chains Are Orderly. Biotech Innovation Is Messy 04/30/13 Boston
Fighting a Global War on Rare Diseases 03/20/13 New York
East Coast Life Sciences Roundup: Zafgen, Moderna, Merck, More 12/07/12 Boston
In Wake of Alzheimer’s Disaster, Wall Street Revisits Pfizer and J&J 08/08/12 New York
iPierian Zeroes In on Antibodies for Alzheimer’s, Neurodegeneration 05/21/12 San Francisco
The Greater Seattle Brain Science Cluster 03/16/12 Seattle
Concert, Alere, TremRx, & More Names from Boston Life Sciences News 03/02/12 Boston
Charles River, FirstFuel, Quiet Logistics, & More Boston Deal News 02/29/12 Boston
Intellect Embraces Wide-Ranging Approach to Fighting Brain Diseases 02/14/12 New York
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
Medivation Fails Alzheimer’s Trial, Pfizer Drops Out of Partnership 01/17/12 San Francisco
Merck Chemists Use High-Tech Science to Combat Alzheimer’s Disease Challenge 12/14/11 New York
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 1) 11/21/11 National
UW Spinoff Impel NeuroPharma Nabs Two Big Pharma Deals, $500K in Angel Financing 10/20/11 Seattle
Xconomist of the Week: Pfizer’s Barbara Dalton to Speak at Our NY Life Sciences 2031 Forum 09/29/11 New York
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News 07/29/11 Boston
EnVivo, Backed by Fidelity Biosciences, Tests New Weapon Against Alzheimer’s 07/25/11 Boston
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs 05/25/11 Boston
23andMe Brings Down the Price of Consumer Genetic Tests, Builds Up Relations With Big Pharma 05/24/11 San Francisco
iPierian, Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives 05/13/11 San Francisco
Hitting the Target, Missing the Mark: How Targeted Therapies Have Left Patients Wanting 04/14/11 Seattle
Medivation, Pfizer Fail Huntington’s Test 04/11/11 San Francisco
NeuroPhage Nets $12.4M to Tackle Alzheimer’s and Other Brain Disorders 03/01/11 Boston
Page 3 of 5 « previous page · next page »